Welcoming Edith Heard to our Board of Trustees
As of October 2023, Prof. Dr. Edith Heard has become the new Chairwoman of the Bayer Foundation Board of Trustees for the Science Program.
Prof. Heard is an exceptional scientist who received her PhD in 1990 in the field of cancer research to be followed by a Postdoctoral Fellow in 1993 at the Institut Pasteur in Paris, France. She has made outstanding impact in the field of epigenetic and has been the Director General of the European Molecular Biology Laboratory (EMBL), one of the biggest research institutions in Europe. In addition, she is the Director, Unit of Genetics and Developmental Biology at the Curie Institute, Paris, France since 2010.
She held the position of Senior Team Leader of Nuclear Dynamics and Genome Plasticity Unit at the French National Centre for Scientific Research (CNRS), Paris, France between 2006 and 2008 and took the role of team Leader of the Research Group at the Curie Institute, Paris, France between 2001 and 2006.
“It is an honour to be appointed as the new chair of the Board of Trustees of the Bayer Foundation in the succession of Prof.Patrick Cramer. I look forward to offering guidance in the attribution of Bayer Foundation's prizes and fellowships rewarding researchers' scientific excellence.”
She is the recipient of many remarkable awards such as, the L’Oréal‐UNESCO For Women in Science Award, the Bayer Foundation Hansen Family Award, the ESHG Award, European Society of Human Genetics (ESHG), the Grand Prix 2017, National Institute of Health and Medical Research (INSERM), and the Otto Mangold Award, Society of Developmental Biology, Heidelberg, Germany in 2007.
Prof. Heard will succeed Prof. Patrick Cramer, who was officially the Chair of the Board of Trustees until end of 2022. Since June 2023, Prof. Cramer is the new president of the Max Planck Society.
We are looking forward to welcome Prof. Dr. Edith Heard in our Board of Trustees and are excited about her scientific expertise which will enrich our science program.
